Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinoma

被引:0
|
作者
Ishihara, Hiroki [1 ]
Fukuda, Hironori [2 ]
Yoshida, Kazuhiko [2 ]
Hashimoto, Yasunobu [3 ]
Kondo, Tsunenori [1 ]
Takagi, Toshio [2 ]
机构
[1] Tokyo Womens Med Univ, Adachi Med Ctr, Dept Urol, Tokyo, Japan
[2] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[3] Saiseikai Kawaguchi Gen Hosp, Dept Urol, Saitama, Japan
关键词
brain metastases; immunotherapy; ipilimumab; nivolumab; RCC; STEREOTACTIC RADIOTHERAPY; THERAPY;
D O I
10.1111/iju.15086
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:240 / 242
页数:3
相关论文
共 50 条
  • [31] Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
    Adashek, Jacob J.
    Salgia, Meghan
    Dizman, Nazli
    Kessler, Jonathan
    Pal, Sumanta K.
    CASE REPORTS IN ONCOLOGY, 2018, 11 (02): : 276 - 280
  • [32] A Contemporary Review of Immune Checkpoint Inhibitors in Advanced Clear Cell Renal Cell Carcinoma
    Yu, Eun-mi
    Linville, Laura
    Rosenthal, Matthew
    Aragon-Ching, Jeanny B.
    VACCINES, 2021, 9 (08)
  • [33] Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Lee, Ji Hyun
    Hwang, Soohyun
    Jee, ByulA
    Kim, Jae-Hun
    Lee, Jihwan
    Chung, Jae Hoon
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Park, Se Hoon
    Kwon, Ghee Young
    Kang, Minyong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [34] Immune Checkpoint Inhibitor in First-Line Treatment of Metastatic Renal Cell Carcinoma: A Review of Current Evidence and Future Directions
    Tung, Iris
    Sahu, Arvind
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma
    Brown, Landon C.
    Zhu, Jason
    Desai, Kunal
    Kinsey, Emily
    Kao, Chester
    Lee, Yong Hee
    Pabla, Sarabjot
    Labriola, Matthew K.
    Tran, Jennifer
    Dragnev, Konstantin H.
    Tafe, Laura J.
    Dayyani, Farshid
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Glenn, Sean T.
    Nesline, Mary K.
    George, Saby
    Zibelman, Matthew
    Morrison, Carl
    Ornstein, Moshe C.
    Zhang, Tian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [36] Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
    Tzeng, Alice
    Tzeng, Tony H.
    Ornstein, Moshe C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [37] Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma
    Flippot, Ronan
    Escudier, Bernard
    Albiges, Laurence
    DRUGS, 2018, 78 (14) : 1443 - 1457
  • [38] Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
    Jang, Albert
    Lichterman, Jake N.
    Zhong, Jeffrey Y.
    Shoag, Jonathan E.
    Garcia, Jorge A.
    Zhang, Tian
    Barata, Pedro C.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [39] Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer
    Kuo, Chih-Hsi Scott
    Wang, Chin-Chou
    Huang, Yu-Chen
    Pavlidis, Stelios
    Liu, Chien-Ying
    Ko, How-Wen
    Chung, Fu-Tsai
    Lin, Tin-Yu
    Wang, Chih-Liang
    Guo, Yi-Ke
    Yang, Cheng-Ta
    THORACIC CANCER, 2019, 10 (05) : 1158 - 1166
  • [40] The Emerging Role of Combination Angiogenesis Inhibitors and Immune Checkpoint Inhibitors in the Treatment of Metastatic Renal Cell Cancer
    Nizam, Amanda
    Rhea, Logan P.
    Gupta, Brinda
    Aragon-Ching, Jeanny B.
    KIDNEY CANCER, 2019, 3 (02) : 81 - 91